DWC Plans to Address Topical Compounds in Treatment Guidelines

Compounding: The Latest Lucrative Loophole?

By: Brad Cain

Repackaged drugs have been regulated into reasonableness. But now another loophole allows medical profiteers to score some extra bling. What is this new cost driver? How serious is it, and what is being done about it? Premium subscribers can get smarter and be prepared by reading all about it, just by clicking this link.

Read More...

This content is for premium subscribers. To read please login or subscribe below.

Subscribe Log In